ACL vs AVE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

53MEDIUM

AVE

AVECHO FPO [AVE]

53MEDIUM

Score Breakdown

ACL AVE
Technical
62
52
Catalyst
88
62
Sentiment
50
50
Fundamental
67
49
Momentum
47
75
Risk Gate
36
45

Key Metrics

ACL Metric AVE
$423.4MMarket Cap$77.3M
520KAvg Volume (20d)24.9M
+7.3%Short InterestN/A
$2.97052-Week High$0.027
$1.83352-Week Low$0.004
+2.0%Daily Change-2.4%
$2.275Entry Price$0.020
+16.7%ROE-182.9%
+3.6%Profit MarginN/A

Active Signals

ACL Signals

●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading above both moving averages — the trend is your friend here
●Above-average volume (1.7x) on a green day — buyers stepping up
●Knocking on the door of resistance — if it punches through, things could get interesting
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)

AVE Signals

●MACD momentum is losing steam
●Beating the Small Ords index — relative strength of 1.65, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Very high P/S ratio (62.4x)
●Revenue in sharp decline (-17%)
●Small-cap ($20-100M)
●Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare ACL and AVE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ACL Full Analysis → AVE Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).